The complementary roles of iron and estrogen in menopausal differences in cardiometabolic outcomes.

Sadat Ahanchi, Noushin; Khatami, Farnaz; Llanaj, Erand; Quezada-Pinedo, Hugo G; Dizdari, Helga; Bano, Arjola; Glisic, Marija; Eisenga, Michele F; Vidal, Pedro-Marques; Muka, Taulant (2024). The complementary roles of iron and estrogen in menopausal differences in cardiometabolic outcomes. Clinical nutrition, 43(5), pp. 1136-1150. Elsevier 10.1016/j.clnu.2024.03.026

[img]
Preview
Text
1-s2.0-S0261561424001006-main.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (2MB) | Preview

Biological hormonal changes are frequently cited as an explanatory factor of sex and menopause differences in cardiometabolic diseases (CMD) and its associated risk factors. However, iron metabolism which varies between sexes and among women of different reproductive stages could also play a role. Recent evidence suggest that iron may contribute to CMD risk by modulating oxidative stress pathways and inflammatory responses, offering insights into the mechanistic interplay between iron and CMD development. In the current review, we provide a critical appraisal of the existing evidence on sex and menopausal differences in CMD, discuss the pitfall of current estrogen hypothesis as sole explanation, and the emerging role of iron in CMD as complementary pathway. Prior to menopause, body iron stores are lower in females as compared to males, but the increase during and after menopause, is tandem with an increased CMD risk. Importantly, basic science experiments show that an increased iron status is related to the development of type 2 diabetes (T2D), and different cardiovascular diseases (CVD). While epidemiological studies have consistently reported associations between heme iron intake and some iron biomarkers such as ferritin and transferrin saturation with the risk of T2D, the evidence regarding their connection to CVD remains controversial. We delve into the factors contributing to this inconsistency, and the limitation of relying on observational evidence, as it does not necessarily imply causation. In conclusion, we provide recommendations for future studies on evaluating the potential role of iron in elucidating the sex and menopausal differences observed in CMD.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

Graduate School:

Graduate School for Health Sciences (GHS)

UniBE Contributor:

Sadat Ahanchi, Noushin, Khatami, Farnaz, Bano, Arjola, Glisic, Marija

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

0261-5614

Publisher:

Elsevier

Funders:

[4] Swiss National Science Foundation ; [73] Swiss Government Excellence Scholarship

Language:

English

Submitter:

Pubmed Import

Date Deposited:

10 Apr 2024 10:28

Last Modified:

18 Apr 2024 10:53

Publisher DOI:

10.1016/j.clnu.2024.03.026

PubMed ID:

38593499

Uncontrolled Keywords:

Cardiometabolic risk factors Iron biomarkers Menopause Sex

BORIS DOI:

10.48350/195830

URI:

https://boris.unibe.ch/id/eprint/195830

Actions (login required)

Edit item Edit item
Provide Feedback